Reuters reveals drugmakers offer Canada C$1 billion to scrap some pending pricing rules

Reuters broke the news that the pharmaceutical industry has made a last-ditch C$1 billion ($761 million) proposal to the Canadian government in hopes of fending off parts of a drug pricing crackdown set to go into effect on Jan. 1. The government has argued that Canada’s patented drug prices are too high, trailing only the United States and Switzerland, and that other countries with lower prices enjoy similar access to prescription medicines.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Equities
Regions: North America
Countries: Canada
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Major Global Story
Sign up for email updates

Sign up for email updates